Hydroxyethyl starch solutions and patient harm

Ian Roberts; Haleema Shakur; Rinaldo Bellomo; Julian Bion; Simon Finfer; Beverley Hunt; John Myburgh; Anders Perner; Konrad Reinhart

doi:10.1016/s0140-6736(18)30255-1

Hydroxyethyl starch solutions and patient harm

Ian Roberts, Haleema Shakur, Rinaldo Bellomo, Julian Bion, Simon Finfer, Beverley Hunt, John Myburgh, Anders Perner, Konrad Reinhart

Department of Clinical Medicine

23 Citations (Scopus)

Original language	English
Journal	Lancet Oncology
Volume	391
Issue number	10122
Pages (from-to)	736
ISSN	1470-2045
DOIs	https://doi.org/10.1016/s0140-6736(18)30255-1
Publication status	Published - 24 Feb 2018

Keywords

Drug Recalls
Europe
Humans
Hydroxyethyl Starch Derivatives/adverse effects
Plasma Substitutes/adverse effects

Access to Document

10.1016/s0140-6736(18)30255-1

http://www.thelancet.com/article/S0140673618302551/pdf

Cite this

@article{586c9c3efe3a43ec83e9b39f85bc8f55,

title = "Hydroxyethyl starch solutions and patient harm",

keywords = "Drug Recalls, Europe, Humans, Hydroxyethyl Starch Derivatives/adverse effects, Plasma Substitutes/adverse effects",

author = "Ian Roberts and Haleema Shakur and Rinaldo Bellomo and Julian Bion and Simon Finfer and Beverley Hunt and John Myburgh and Anders Perner and Konrad Reinhart",

year = "2018",

month = feb,

day = "24",

doi = "10.1016/s0140-6736(18)30255-1",

language = "English",

volume = "391",

pages = "736",

journal = "Lancet Oncology",

issn = "1470-2045",

publisher = "TheLancet Publishing Group",

number = "10122",

}

TY - JOUR

T1 - Hydroxyethyl starch solutions and patient harm

AU - Roberts, Ian

AU - Shakur, Haleema

AU - Bellomo, Rinaldo

AU - Bion, Julian

AU - Finfer, Simon

AU - Hunt, Beverley

AU - Myburgh, John

AU - Perner, Anders

AU - Reinhart, Konrad

PY - 2018/2/24

Y1 - 2018/2/24

KW - Drug Recalls

KW - Europe

KW - Humans

KW - Hydroxyethyl Starch Derivatives/adverse effects

KW - Plasma Substitutes/adverse effects

U2 - 10.1016/s0140-6736(18)30255-1

DO - 10.1016/s0140-6736(18)30255-1

M3 - Comment/debate

C2 - 29449012

SN - 1470-2045

VL - 391

SP - 736

JO - Lancet Oncology

JF - Lancet Oncology

IS - 10122

ER -